105 related articles for article (PubMed ID: 2423185)
1. The co-occurrence of substance P-like immunoreactivity and dynorphin-like immunoreactivity in striatopallidal and striatonigral projection neurons in birds and reptiles.
Reiner A
Brain Res; 1986 Apr; 371(1):155-61. PubMed ID: 2423185
[TBL] [Abstract][Full Text] [Related]
2. Extensive co-occurrence of substance P and dynorphin in striatal projection neurons: an evolutionarily conserved feature of basal ganglia organization.
Anderson KD; Reiner A
J Comp Neurol; 1990 May; 295(3):339-69. PubMed ID: 1693632
[TBL] [Abstract][Full Text] [Related]
3. The distribution of dynorphinergic terminals in striatal target regions in comparison to the distribution of substance P-containing and enkephalinergic terminals in monkeys and humans.
Reiner A; Medina L; Haber SN
Neuroscience; 1999; 88(3):775-93. PubMed ID: 10363817
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of suicide transport lesions of the striatonigral or striatopallidal pathways on subsets of striatal neurons.
Roberts RC; Harrison MB; Francis SM; Wiley RG
Exp Neurol; 1993 Dec; 124(2):242-52. PubMed ID: 7507060
[TBL] [Abstract][Full Text] [Related]
5. Dual role for Islet-1 in promoting striatonigral and repressing striatopallidal genetic programs to specify striatonigral cell identity.
Lu KM; Evans SM; Hirano S; Liu FC
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):E168-77. PubMed ID: 24351932
[TBL] [Abstract][Full Text] [Related]
6. Striatonigral projection neurons: a retrograde labeling study of the percentages that contain substance P or enkephalin in pigeons.
Anderson KD; Reiner A
J Comp Neurol; 1991 Jan; 303(4):658-73. PubMed ID: 1707424
[TBL] [Abstract][Full Text] [Related]
7. Effect of neonatal hypoxia-ischemia on nigro-striatal dopamine receptors and on striatal neuropeptide Y, dynorphin A and substance P concentrations in rats.
Johnson M; Hanson GR; Gibb JW; Adair J; Filloux F
Brain Res Dev Brain Res; 1994 Nov; 83(1):109-18. PubMed ID: 7535199
[TBL] [Abstract][Full Text] [Related]
8. Differential changes in striatal projection neurons in R6/2 transgenic mice for Huntington's disease.
Sun Z; Del Mar N; Meade C; Goldowitz D; Reiner A
Neurobiol Dis; 2002 Dec; 11(3):369-85. PubMed ID: 12586547
[TBL] [Abstract][Full Text] [Related]
9. Loss of substance P and enkephalin immunoreactivity in the human substantia nigra after striato-pallidal infarction.
Pioro EP; Hughes JT; Cuello AC
Brain Res; 1984 Feb; 292(2):339-47. PubMed ID: 6198046
[TBL] [Abstract][Full Text] [Related]
10. Gilles de la Tourette's syndrome. A postmortem neuropathological and immunohistochemical study.
Haber SN; Kowall NW; Vonsattel JP; Bird ED; Richardson EP
J Neurol Sci; 1986 Sep; 75(2):225-41. PubMed ID: 2428943
[TBL] [Abstract][Full Text] [Related]
11. In vivo biosynthesis of [35S]- and [3H]substance P in the striatum of the rat and their axonal transport to the substantia nigra.
Krause JE; Reiner AJ; Advis JP; McKelvy JF
J Neurosci; 1984 Mar; 4(3):775-85. PubMed ID: 6200582
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's disease.
Marshall PE; Landis DM; Zalneraitis EL
Brain Res; 1983 Dec; 289(1-2):11-26. PubMed ID: 6198034
[TBL] [Abstract][Full Text] [Related]
13. Topographic intermingling of striatonigral and striatopallidal neurons in the rhesus monkey.
Selemon LD; Goldman-Rakic PS
J Comp Neurol; 1990 Jul; 297(3):359-76. PubMed ID: 1697864
[TBL] [Abstract][Full Text] [Related]
14. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study.
Gerfen CR; Young WS
Brain Res; 1988 Sep; 460(1):161-7. PubMed ID: 2464402
[TBL] [Abstract][Full Text] [Related]
15. Expression of D4 dopamine receptors in striatonigral and striatopallidal neurons in the rat striatum.
Rivera A; Trías S; Peñafiel A; Angel Narváez J; Díaz-Cabiale Z; Moratalla R; de la Calle A
Brain Res; 2003 Oct; 989(1):35-41. PubMed ID: 14519509
[TBL] [Abstract][Full Text] [Related]
16. Single-cell RT-PCR, in situ hybridization histochemical, and immunohistochemical studies of substance P and enkephalin co-occurrence in striatal projection neurons in rats.
Wang HB; Laverghetta AV; Foehring R; Deng YP; Sun Z; Yamamoto K; Lei WL; Jiao Y; Reiner A
J Chem Neuroanat; 2006 Apr; 31(3):178-99. PubMed ID: 16513318
[TBL] [Abstract][Full Text] [Related]
17. Topographic projections of substance P and GABA pathways in the striato- and pallido-nigral system: a biochemical and immunohistochemical study.
Jessell TM; Emson PC; Paxinos G; Cuello AC
Brain Res; 1978 Sep; 152(3):487-98. PubMed ID: 356929
[TBL] [Abstract][Full Text] [Related]
18. Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats.
Engber TM; Susel Z; Kuo S; Gerfen CR; Chase TN
Brain Res; 1991 Jun; 552(1):113-8. PubMed ID: 1717109
[TBL] [Abstract][Full Text] [Related]
19. Substance P: localization within paleostriatal-tegmental pathways in the pigeon.
Reiner A; Karten HJ; Solina AR
Neuroscience; 1983 May; 9(1):61-85. PubMed ID: 6192356
[No Abstract] [Full Text] [Related]
20. Splice variants of glutamate receptor subunits 2 and 3 in striatal projection neurons.
Tallaksen-Greene SJ; Albin RL
Neuroscience; 1996 Dec; 75(4):1057-64. PubMed ID: 8938741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
